Int J Oncol 44: [Related article:] 1233-1242, 2014; DOI:
10.3892/ijo.2014.2297
Following the publication of this paper, it was
drawn to the Editor's attention by a concerned reader that a pair
of data panels (namely, the A549T-eto/FERO, 1 mM and FERO, 12 h
panels) in the cell viability experiments shown in Fig. 1B on p.
1235 were partially overlapping, where the data had apparently been
derived from the same original source. After having performed an
independent review of the data in the Editorial Office, also in
Fig. 1B, another pair of overlapping data panels were identified;
moreover, strikingly similar data for the α-P-glycoprotein blots
had been included in different figures (Figs. 1C and 3B), and there
appeared to be a splicing event/break in the continuity of the
α-actin bands shown for the control data in Figs. 1C and 3B that
wasn't apparent elsewhere for the proteins of interest shown in
these figure parts.
Owing to these possible anomalies and the
duplications of the data that have been identified in this paper,
the Editor of International Journal of Oncology has decided
that it should be retracted from the Journal on account of a lack
of confidence in the presented data. After having been in contact
with the authors, they accepted the decision to retract the paper.
The Editor apologizes to the readership for any inconvenience
caused.
